206 related articles for article (PubMed ID: 8457653)
1. The polymerization of fibrinogen Dusart (A alpha 554 Arg-->Cys) after removal of carboxy terminal regions of the A alpha-chains.
Siebenlist KR; Mosesson MW; DiOrio JP; Soria J; Soria C; Caen JP
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):61-5. PubMed ID: 8457653
[TBL] [Abstract][Full Text] [Related]
2. The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome".
Mosesson MW; Siebenlist KR; Hainfeld Jf; Wall JS; Soria J; Soria C; Caen JP
J Clin Invest; 1996 May; 97(10):2342-50. PubMed ID: 8636415
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia.
Koopman J; Haverkate F; Grimbergen J; Lord ST; Mosesson MW; DiOrio JP; Siebenlist KS; Legrand C; Soria J; Soria C
J Clin Invest; 1993 Apr; 91(4):1637-43. PubMed ID: 8473507
[TBL] [Abstract][Full Text] [Related]
4. The ultrastructure of fibrinogen-420 and the fibrin-420 clot.
Mosesson MW; DiOrio JP; Hernandez I; Hainfeld JF; Wall JS; Grieninger G
Biophys Chem; 2004 Dec; 112(2-3):209-14. PubMed ID: 15572250
[TBL] [Abstract][Full Text] [Related]
5. The polymerization of fibrin prepared from fibrinogen Haifa (gamma 275Arg----His).
Siebenlist KR; Mosesson MW; Di Orio JP; Tavori S; Tatarsky I; Rimon A
Thromb Haemost; 1989 Nov; 62(3):875-9. PubMed ID: 2512677
[TBL] [Abstract][Full Text] [Related]
6. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Dusart: electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots.
Collet JP; Woodhead JL; Soria J; Soria C; Mirshahi M; Caen JP; Weisel JW
Biophys J; 1996 Jan; 70(1):500-10. PubMed ID: 8770228
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly.
Mosesson MW
Blood Coagul Fibrinolysis; 1997 Jul; 8(5):257-67. PubMed ID: 9282789
[TBL] [Abstract][Full Text] [Related]
9. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
10. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
[TBL] [Abstract][Full Text] [Related]
11. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization.
Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS
Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen anomalies and disease. A clinical update.
Galanakis DK
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1171-87. PubMed ID: 1400080
[TBL] [Abstract][Full Text] [Related]
13. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
Matsuda M; Baba M; Morimoto K; Nakamikawa C
J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
[TBL] [Abstract][Full Text] [Related]
14. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.
Mosesson MW; Siebenlist KR; Hainfeld JF; Wall JS
J Struct Biol; 1995; 115(1):88-101. PubMed ID: 7577232
[TBL] [Abstract][Full Text] [Related]
15. Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure.
Collet JP; Soria J; Mirshahi M; Hirsch M; Dagonnet FB; Caen J; Soria C
Blood; 1993 Oct; 82(8):2462-9. PubMed ID: 7691261
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA).
Marchi R; Carvajal Z; Meyer M; Soria J; Ruiz-Saez A; Arocha-Piñango CL; Weisel JW
Thromb Res; 2006; 118(5):637-50. PubMed ID: 16406498
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).
Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T
Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen New Britain: characterization of an A alpha Arg 16-->His variant human fibrinogen.
Webb CD; Hantgan RR; Byeff PD; Owen J
Blood Coagul Fibrinolysis; 1994 Apr; 5(2):233-8. PubMed ID: 8054455
[TBL] [Abstract][Full Text] [Related]
20. Cross-linked alpha s gamma t-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting.
Grøn B; Filion-Myklebust C; Bjørnsen S; Haidaris P; Brosstad F
Thromb Haemost; 1993 Sep; 70(3):438-42. PubMed ID: 8259545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
